Seelos Therapeutics
SEEL
#10397
Rank
A$0.34 M
Marketcap
$0.59
Share price
-31.49%
Change (1 day)
-99.73%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): A$6.95 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$60.77 Million, an increase over its 2022 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$6.95 M-111.45%
2023 -A$60.77 Million-48.58%
2022 -A$0.12 Billion14.07%
2021 -A$0.11 Billion240.34%
2020 -A$30.44 Million-62.76%
2019 -A$81.73 Million587.73%
2018 -A$11.89 Million-36.54%
2017 -A$18.73 Million74.83%
2016 -A$10.72 Million-63.26%
2015 -A$29.16 Million-18.06%
2014 -A$35.59 Million46.19%
2013 -A$24.34 Million-31.67%
2012 -A$35.63 Million
2010 -A$33.37 Million448.63%
2009 -A$6.09 Million-25.83%
2008 -A$8.21 Million-45.65%
2007 -A$15.09 Million2.82%
2006 -A$14.68 Million-41.86%
2005 -A$25.24 Million-9.27%
2004 -A$27.82 Million114.92%
2003 -A$12.95 Million-70.78%
2002 -A$44.3 Million60.2%
2001 -A$27.65 Million70.3%
2000 -A$16.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion-3,309.93%๐Ÿ‡บ๐Ÿ‡ธ USA